Related Experiment Video

Updated: Jun 24, 2026

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

Machine Learning for Monoclonal Gammopathy of Undetermined Significance Screening: Who, How, and Why?

Aheli Dutta1, Rahul Banerjee1,2

  • 1University of Washington, Seattle, WA.

JCO Clinical Cancer Informatics
|June 22, 2026
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Related Experiment Videos

Last Updated: Jun 24, 2026

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

Articles linked to this work by shared authors, journal, and citation graph.

Sequenced, Not Stirred: Positioning CAR T and Bispecific Antibody Therapy in Multiple Myeloma.

Blood cancer discovery·2026

Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.

Blood·2026

Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.

Blood advances·2026

Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

The New England journal of medicine·2026

Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

How we prevent infections in adults receiving bispecific antibody therapies for advanced B-cell malignancies.

Blood·2026

Early Unplanned Readmissions and Mortality After Induction Chemotherapy in AML.

JCO clinical cancer informatics·2026

Data Extraction From Oncology Imaging Reports by Large Language Models: A Comparative Accuracy Study.

JCO clinical cancer informatics·2026

Consensus-Based Minimum Requirements for the Adoption of a Computational Pathology Algorithm for Tumor Budding in Colorectal Cancer: An Early Health Technology Assessment.

JCO clinical cancer informatics·2026

Validation of a Text-Mining Tool for Extracting Routine Clinical Care Data in Early-Stage Resectable Non-Small Cell Lung Cancer.

JCO clinical cancer informatics·2026

Clinical Impact of Mismatch Repair Gene Mutation-Based Alert on Immunotherapy Decision Making Across Patients With Cancer.

JCO clinical cancer informatics·2026

Strategies for Deploying Large Language Models for Ascertaining Clinical Outcomes and Sites of Metastases From Radiology Impressions in Patients With Cancer.

JCO clinical cancer informatics·2026

The pseudouridine synthase PUSL1 modifies U39 of mitochondrial tRNAs and is linked to human neurological phenotypes.

Nucleic acids research·2026

TEAD inhibitors re-sensitize drug-resistant NF1 MPNST cells to MEK inhibitors.

microPublication biology·2026

Clinical application of PIRCHE scores: reclassifying immunologic risk in patients with medium eplet mismatch.

Frontiers in immunology·2026

Synergistic optimization strategy for high-performance multilayer SPR biosensor.

Optics express·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us